Direkt zum Inhalt

Literaturhinweise

  1. Bray et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2018;68:394–424.
  2. Die We-Care-Umfrage 2017 wurde von Atomik Research, London, UK vom 6. – 23. Januar 2017 durchgeführt.
  3. National Cancer Institute. [Internet; zitiert am 5. April 2019] Verfügbar ab: http://seer.cancer.gov/statfacts/html/urinb.html.
  4. Patient. [Internet; zitiert am 5. April 2019] Verfügbar ab: http://patient.info/health/bladder-cancer-leaflet
  5. NHS. [Internet; zitiert am 5. April 2019] Verfügbar ab: https://www.nhs.uk/conditions/bladder-cancer/symptoms/.
  6. Fight bladder cancer. [Internet; zitiert am 5. April 2019] Verfügbar ab: http://fightbladdercancer.co.uk/learn/symptoms
  7. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Dobruch J et al. Eur Urol. 2016;69:300-310.
  8. Richards K.A et al. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities. Int J Urol. 2016;23:42-47.
  9. Nicholson, B. D et al. Bladder cancer in women. BMJ. 2014;348:g2171-g2171.